PMI seeks scientists for new wave of its Postdoctoral Fellowship Program

04 Jul 2019
Are you looking for a new opportunity? Put your PhD into practice to build a smoke-free future
cube outside thumnail
With a focus on the research and development of better alternatives for adult smokers who would otherwise continue smoking, Philip Morris International (PMI) is welcoming applications to the new wave of its Postdoctoral Fellowship Program, scheduled to start in the autumn.

Nine scientists are invited to apply for this unique opportunity, and the two-year program will be based in PMI’s state-of-the-art Science & Innovation facility, aka ‘the Cube’, in Neuchâtel, Switzerland.

The selected candidates will join a team of more than 430 scientists, engineers and technicians, working together to create and innovate. Those chosen for the Program will receive expert guidance from a mentor and have the chance to publish their research in leading journals. They will also benefit from being in an international, flexible working environment, with PMI having been certified as a Global Top Employer.

The nine areas of the Postdoctoral Fellowship Program are:

  • Tobacco Biology
  • Protein-adduct
  • SensoCytes
  • Neuroinflammation
  • Aerosol Chemistry
  • Aerosol testing Concepts
  • Artificial Intelligence
  • Biomarkers Discovery
  • Breathomics

The Postdoctoral Fellowship Program was first launched in 2017, with seven candidates enrolling to research a variety of topics, from plant genomics to human behavioral psychology. These postdocs have contributed greatly to our growing knowledge on the science behind tobacco and alternatives to smoking.

Maxime Magnier, P&C Biomedical Research Manager and coordinator of the Postdoctoral Fellowship Program, said: “When I took over the coordination of this project, I was just amazed by the leadership expressed by our seven postdocs along with the quality of their work and their impressive achievements over the past 18 months. The Program is crucial for PMI, as it wants to bring in diverse scientific talents to create the best science, which will allow us to achieve our extraordinary transformation. I’m really eager to welcome the nine new postdocs.”

This program is crucial for PMI, as it wants to bring in diverse scientific talents to create the best science, which will allow us to achieve our extraordinary transformation
Maxime Magnier, P&C Biomedical Research Manager

Since 2008, PMI has invested more than $6 billion into the research and development of our smoke-free products. The World Health Organization has estimated there are 1.1 billion smokers in the world today. By 2025, it is estimated there will still be over 1 billion. That number needs to change.

Addressing the world’s 1 billion smokers, the best thing they can do is to quit cigarettes and nicotine altogether. However, in any given year, a large population of existing smokers will continue to smoke, and we believe they deserve better alternatives.

This is why we have committed time, money and resources to developing and scientifically assessing these products, and we invite others to read and verify our science. PMI sets itself high standards and its rigorous development and assessment program from smoke-free products is inspired by the pharmaceutical industry’s practices for novel drugs.

To make a real difference to the lives of millions of adult smokers, PMI needs the best talents. That’s why the company prides itself on its people and culture. It seeks to provide employees with a diverse and inclusive working environment, offering flexibility and equal salaries.

Applications for the Postdoctoral Fellowship Program are already open, with interviews expected to take place over the summer. Successful applicants will be expected to start in the autumn. For more information on the vacancies and how to apply, visit the PMI Science website.

Share this